13-Methyltetradecanoic acid-d6

13-Methyltetradecanoic acid-d6 is a deuterated labeled 13-Methyltetradecanoic acid[1]. 13-Methyltetradecanoic acid (13-MTD), a saturated branched-chain fatty acid with potent anticancer effects. 13-Methyltetradecanoic acid induces apoptosis in many types of human cancer cells[2][3].

Product Specifications

Product Name Alternative

13-MTD-d6; 13-Methylmyristic acid-d6

UNSPSC

12352211

Target

Apoptosis; Isotope-Labeled Compounds

Related Pathways

Apoptosis; Others

Field of Research

Cancer

Smiles

O=C(O)CCCCCCCCCCCC(C([2H])([2H])[2H])C([2H])([2H])[2H]

Molecular Formula

C15H24D6O2

Molecular Weight

248.43

References & Citations

[1]Tianxin Lin, et al. 13-Methyltetradecanoic acid induces mitochondrial-mediated apoptosis in human bladder cancer cells. Urol Oncol. May-Jun 2012;30 (3) :339-45.|[2]Qingqing Cai, et al. 13-methyltetradecanoic acid exhibits anti-tumor activity on T-cell lymphomas in vitro and in vivo by down-regulating p-AKT and activating caspase-3. PLoS One. 2013 Jun 7;8 (6) :e65308.|[3]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.